Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.

Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes.

To investigate associations between imaging features of cholangiocarcinoma by visual assessment and texture analysis, which quantifies heterogeneity in tumor enhancement patterns, with molecular profiles based on hypoxia markers.The institutional review board approved this HIPAA-compliant retrospect...

Full description

Bibliographic Details
Main Authors:	Eran Sadot, Amber L Simpson, Richard K G Do, Mithat Gonen, Jinru Shia, Peter J Allen, Michael I D'Angelica, Ronald P DeMatteo, T Peter Kingham, William R Jarnagin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4514866?pdf=render

Similar Items

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
by: Jian Zheng, et al.
Published: (2018-01-01)

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma.
by: Camilo Correa-Gallego, et al.
Published: (2016-01-01)

Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
by: Hiromichi Ito, et al.
Published: (2013-01-01)

Outcome of patients with perihilar cholangiocarcinoma and previous biliary instrumentation: an observational study
by: Karen T. Brown, et al.
Published: (2024-05-01)

The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.
by: J Bart Rose, et al.
Published: (2016-01-01)

Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival
by: Kevin C. Soares, et al.
Published: (2023-06-01)

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
by: Blumgart Leslie H, et al.
Published: (2009-05-01)

Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival
by: Sara Velayati, et al.
Published: (2023-10-01)

Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases
by: Amber L. Simpson, et al.
Published: (2024-02-01)

Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.
by: Serge Evrard, et al.
Published: (2014-01-01)

Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases
by: Pieter MH Nierop, et al.
Published: (2022-01-01)

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers.
by: Jordan M. Winter, et al.
Published: (2012-01-01)

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
by: Jordan M Winter, et al.
Published: (2012-01-01)

Bias, Biostatistics, and Prognostic Factors
by: Mithat Gonen
Published: (2014-02-01)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
by: Vlasios S. Sotirchos, et al.
Published: (2014-01-01)

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
by: Julien Calderaro, et al.
Published: (2023-12-01)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
by: Manida Suksawat, et al.
Published: (2022-02-01)

Building a Nomogram for Survey-Weighted Cox Models Using R
by: Marinela Capanu, et al.
Published: (2015-03-01)

Molecular Pathogenesis of Cholangiocarcinoma
by: Peter L. Labib, et al.
Published: (2019-02-01)

Targeted Therapies in Advanced Cholangiocarcinoma
by: Michael H. Storandt, et al.
Published: (2023-10-01)

High expression of tissue -linked glycans is associated with a malignant phenotype of cholangiocarcinoma
by: Krajang Talabnin, et al.
Published: (2021-02-01)

Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma.
by: Chiara Braconi, et al.
Published: (2010-12-01)

Phenotypic correlates of the working dog microbiome
by: Hillary A. Craddock, et al.
Published: (2022-08-01)

Cutaneous Cholangiocarcinoma: An Interesting Presentation
by: Gregory Greco, DO, FACS, et al.
Published: (2020-08-01)

The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma
by: David Malka, et al.
Published: (2020-11-01)

Radiomics artificial intelligence modelling for prediction of local control for colorectal liver metastases treated with radiotherapy
by: Ricky Hu, et al.
Published: (2022-10-01)

HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype
by: Xiaojing Du, et al.
Published: (2023-01-01)

CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
by: Nattawan Suwannakul, et al.
Published: (2020-06-01)

Correlation analysis of MR elastography and Ki-67 expression in intrahepatic cholangiocarcinoma
by: Shanshan Gao, et al.
Published: (2023-11-01)

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma
by: Linping Xu, et al.
Published: (2022-09-01)

Genotype–phenotype correlations within the Geodermatophilaceae
by: Maria del Carmen Montero-Calasanz, et al.
Published: (2022-11-01)

Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery
by: Andrew D. Speers, et al.
Published: (2018-10-01)

Precursors to Cholangiocarcinoma
by: Tomas Hucl
Published: (2019-01-01)

Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)

Necroptosis in Cholangiocarcinoma
by: Samantha Sarcognato, et al.
Published: (2020-04-01)

Diagnosis of Cholangiocarcinoma
by: Dong Woo Shin, et al.
Published: (2023-01-01)

Pathology of Cholangiocarcinomas
by: Nathalie Guedj
Published: (2022-12-01)

Immunobiology of cholangiocarcinoma
by: Emilien Loeuillard, et al.
Published: (2019-10-01)

Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma
by: Tian, Y, et al.
Published: (2021)

CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
by: Serena Mancarella, et al.
Published: (2022-02-01)